Home · News · Scoring Systems · ICU Database · Red Apple Break · IPACCMS · smartICU · Downloads · Forum · Search Thursday, August 07, 2008
PubMed RSS
CCM Journals RSS
SCCM Journal
Critical Care Forum
BMC Pulmonary
Learn ICU
NEJM Feeds
Current Issue
Four Most Recent Issues
CCM Collection
Image of the Week
Most Viewed
Most Cited
Evidence Based Critical Care
CACCT Library
Structured Abstracts
Journal Club
ICU Medicus Resources
Professional Education
CCM Guidelines
Core Lectures
Featured Articles
ICU Cases
Microbiology Trivia
ICU Procedures
Decision Support
Scoring Systems
Clinical Criteria
ICU Calculators
ICU Case of the Week
Medical Images
Mechanical Ventilation
Waveform Analysis
X-Rays
EKG Interpretation
Professional Resources
PubMed
ICU Medicus Library
Free Full Text Journals
Free CME Sites
Web Links

ICU Scores: New Simplified Acute Physiology Score (SAPS II)

A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study

JAMA 1994 May 4;271(17):1321
Le Gall JR, Lemeshow S, Saulnier F.

Faculty of Medicine Lariboisiere-Saint-Louis, Paris, France.

OBJECTIVE--To develop and validate a new Simplified Acute Physiology Score, the SAPS II, from a large sample of surgical and medical patients, and to provide a method to convert the score to a probability of hospital mortality. DESIGN AND SETTING--The SAPS II and the probability of hospital mortality were developed and validated using data from consecutive admissions to 137 adult medical and/or surgical intensive care units in 12 countries. PATIENTS--The 13,152 patients were randomly divided into developmental (65%) and validation (35%) samples. Patients younger than 18 years, burn patients, coronary care patients, and cardiac surgery patients were excluded. OUTCOME MEASURE--Vital status at hospital discharge. RESULTS--The SAPS II includes only 17 variables: 12 physiology variables, age, type of admission (scheduled surgical, unscheduled surgical, or medical), and three underlying disease variables (acquired immunodeficiency syndrome, metastatic cancer, and hematologic malignancy). Goodness-of-fit tests indicated that the model performed well in the developmental sample and validated well in an independent sample of patients (P = .883 and P = .104 in the developmental and validation samples, respectively). The area under the receiver operating characteristic curve was 0.88 in the developmental sample and 0.86 in the validation sample. CONCLUSION--The SAPS II, based on a large international sample of patients, provides an estimate of the risk of death without having to specify a primary diagnosis. This is a starting point for future evaluation of the efficiency of intensive care units

SAPS II Calculator
  • Enter the lowest and the highest values for the physiologic parameter
  • Use the worse values during the 24 hour period
Select the Unit:
STD Units SI Units
Lowest
Highest
Lowest Highest
Temperature :
°F°C
Sodium (mmol/L)
Systolic BP (mm Hg):
potassium (mmol/L)
Heart Rate (/m):
BUN
MV or CPAP
Bilirubin
Fio2 (%):
HCO3 (mmol/L):
PO2:
WBC (x103/ mm3 )
Urine Output
GCS (calculate)
Type of Admission
Chronic Disease
AGE
SAPS Score 
Predicted Mortality Rate

Glascow Coma Score

Eyes Opening

Verbal Response

Motor Response

spontaneous
to speech
to pain
absent

converses & oriented
converses & dsoriented
iappropriate
incomprehensible
absent

obeys
localizes pain
withdraws (flexion)
decorticate (flexion) rigidity
decerebrate (extension) rigidity
absent

Glasgow Coma Score=

Up to SAPS II

Chronic Health Conditions

AIDS

HIV positive with clinical complications as pneumocystis carinii pneumonia, Kaposi's sarcoma, Lymphoma, tuberculosis or toxoplasma infection
Hematologic malignancy lymphoma, acute leukemia, or multiple myeloma
Metastatic cancer proven metastasis by surgery, C.T. scan or any other method

Up to SAPS II

ICU Scores APACHE II SAPS II MPM-0 MPM-24 MPM-48 MPM-Over Time SOFA MODS PRISM

Guest
Username

Password

Remember Me



Register
Lost Password?
You Tube Videos
Medical Malpractice
Central Line Placement



Education Calendars

Copyright © 2004 Mazen Kherallah